Next Article in Journal
Comparative Transcriptomic Profiling to Understand Pre- and Post-Ripening Hormonal Regulations and Anthocyanin Biosynthesis in Early Ripening Apple Fruit
Next Article in Special Issue
Metal Chelating, Inhibitory DNA Damage, and Anti-Inflammatory Activities of Phenolics from Rambutan (Nephelium lappaceum) Peel and the Quantifications of Geraniin and Corilagin
Previous Article in Journal
UV-Denaturation Assay to Assess Protein Photostability and Ligand-Binding Interactions Using the High Photon Flux of Diamond B23 Beamline for SRCD
Previous Article in Special Issue
Chemical Composition and Antibacterial Activity of Essential Oils from Ferula L. Species against Methicillin-Resistant Staphylococcus aureus
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Isolation and Purification of Potent Growth Inhibitors from Piper methysticum Root

Graduate school for International Development and Cooperation, Hiroshima University, Hiroshima 739-8529, Japan
*
Author to whom correspondence should be addressed.
Molecules 2018, 23(8), 1907; https://doi.org/10.3390/molecules23081907
Submission received: 10 July 2018 / Revised: 20 July 2018 / Accepted: 28 July 2018 / Published: 31 July 2018
(This article belongs to the Special Issue Discovery of Active Ingredients from Natural Products)

Abstract

:
Piper methysticum (kava) root is known to possess promising weed suppressing activity. The present study was conducted to search for potent plant growth inhibitors from the root of this medicinal pepper plant. The ethyl acetate (EtOAc) extract exhibited the strongest reduction on growth of Raphanus sativus (radish) (IC50 shoot and root growth = 172.00 and 51.31 µg/mL respectively) among solvent extracts. From this active extract, nine potent growth inhibitors involved in the inhibitory activities of P. methysticum root were isolated, purified and characterized by column chromatography (CC), gas chromatography-mass spectrometry (GC-MS), electrospray ionization-mass spectrometry (ESI-MS) and nuclear magnetic resonance (NMR). The six fractions purified by CC included two flavanones: 5-hydroxy-4′,7-dimethoxyflavanone (C1) and 5,7-dihydroxy-4′-methoxy-6,8-dimethylflavanone (matteucinol, C2) and six kavalactones: 5,6-dehydro-kavain (C3), a mixture of kavain and yagonin (C4), yagonin (C5) and dihydro-5,6-dehydrokavain, 7,8-dihydrokavain, dihydromethysticin and methysticin (C6). The amounts of 5-hydroxy-4′,7-dimethoxyflavanone, matteucinol, 5,6-dehydrokavain and yangonin were 0.76, 2.50, 2.75 and 2.09 mg/g dry weight (DW), respectively. The two flavanones C1 and C2 exhibited the strongest inhibition on shoot elongation (IC50 = 120.22 and 248.03 µg/mL, respectively), whilst the two kavalactone mixtures C4 and C6 showed the highest suppression on root growth of R. sativus (IC50 = 7.70 and 15.67 µg/mL, respectively). This study was the first to report the purification and inhibitory activities of the two flavanones 5-hydroxy-4′,7-dimethoxyflavanone and matteucinol in P. methysticum root. The isolated constituents from P. methysticum root including the flavanones C1 and C2 and the mixtures C4 and C6 may possess distinct modes of action on plant growth. Findings of this study highlighted that the combinations of hexane-ethyl acetate by 9:1 and 8:2 ratios successfully purified flavanones and kavalactones in P. methysticum root.

1. Introduction

Allelopathy is described as a phenomenon by which a plant possesses a natural ability to either inhibit or stimulate the growth of other plants in its vicinity by its biological toxins [1]. Taking advantages of this antagonistic plant–plant interaction, growth inhibitors from many plants have been examined for weed management. Since synthetic herbicides have negative impacts on environment and on human health, natural-based herbicide application is considered as an alternative tool to manage weeds in crop cultivation and establish a sustainable agriculture [2].
Piper methysticum G. Frost, belonging to the family Piperaceae, is a medical herb native to the South Pacific region [3]. The plant has long been reputed as an indispensable beverage for ceremonial and ritual purposes in Polynesia [3,4]. The consumption of Piper methysticum provides positive health effects, such as reduction of anxiety disorders, urinary tract infections and muscle relaxation [5,6]. Besides, root of P. methysticum which is commonly left after extraction showed promising inhibition on spontaneous growth of paddy weeds [7]. It was reported that extracts of P. methysticum root retard plant growth and possess potent allelochemicals [8,9,10]. Six kavalactones derived from P. methysticum root were purchased and examined for herbicidal and antifungal activities [9]. In addition, eight phenolic acids involved in inhibition against the harmful paddy weed Echinochloa crus-galli (barnyardgrass), were putatively identified and quantified by high performance-liquid chromatography (HPLC). Principal plant growth inhibitors of P. methysticum root belonged to the kavalactone group, which is differ chemically in their pyrone moieties [9]. In addition, whether the roots of P. methysticum contain effective growth inhibitors other than kavalactones and phenolic acids, requires further investigation.
This study carried out bioassay-guided trials of P. methysticum inhibition on growth of R. sativus according to different extracting solvents and fractions separated by column chromatography (CC). Gas chromatography-mass spectrometry (GC-MS), electrospray ionization-mass spectrometry (ESI-MS) and nuclear magnetic resonance (1H- and 13C-NMR) were used to determine the chemical structures of isolated and bioactive constituents. The inhibitory levels of purified and identified compounds from P. methysticum root were also determined and characterized.

2. Results

2.1. Inhibitory Effect of Different Extracts of P. methysticum Root

Table 1 shows the inhibitory levels of extracts with solvents with different polarity (hexane, chloroform, ethyl acetate, acetone and water). It was found that all extracts exhibited some reduction of the elongations of shoot and root of R. sativus. In general, the strength of the inhibitory activities was proportional to the applied doses.
To compare the inhibitory levels among different solvent extracts, IC50 values were used. This represents the quantity of the extract needed to suppress 50% of the shoot and root growth of R. sativus. Therefore, a lower IC50 value indicates a stronger inhibitory activity. The results of inhibition on root and shoot length of R. sativus expressed as IC50 values are presented in Table 2. Among solvent extracts, the ethyl acetate (EtOAc) extract showed the highest inhibitory levels on root and shoot (IC50 = 51.31 and 172.00 µg/mL, respectively). Consequently, the suppressive strength could be ranked in the following order: EtOAc > chloroform > acetone > hexane > water. The greater inhibition of the EtOAc extract implied that it might contain more potent growth inhibitors than the other extracts, therefore, this fraction was selected for further analysis.

2.2. Isolation and Purification of Plant Growth Inhibitors by Column Chromatography

Various combinations of solvents for column chromatography (CC) were examined, of which the mixture of hexane (H) and ethyl acetate (E) was the most effective to separate the constituents of the EtOAc extract (data not shown). Finally, the combinations of H:E at ratios 9:1 and 8:2 successfully separated six different fractions identified as C1C6 (Table 3).
Next, the fractions were characterized by GC-MS, ESI-MS and 1H- and 13C-NMR to identify their chemical components. From 165.9 g powder Piper methysticum root, a total of 6.5 g of EtOAc extract was isolated and fractionated by CC (Table 4) into the following fractions: 5,6-dehydrokavain (174.4 mg, C3), yangonin (70.3 mg, C5), 5-hydroxy-4′,7-dimethoxyflavanone (7.7 mg, C1) and matteucinol (54.7 mg, C2) (Table 3 and Table 4). The other two solids were mixtures of kavain (59.42%) and yagonin (40.58%) (C4) and dihydro-5,6-dehydrokavain (12.78%), 7,8-dihydrokavain (20.44%), dihydromethysticin (54.77%) and methysticin (8.90%) (C6, Table 4). The chemical structures of these compounds were elucidated based on their spectroscopic data (Figure 1, Table 4) (Supplementary data, Figures S1–S24). The mixture C4 afforded the highest yield (518.0 mg), whereas the fraction C1 provided the minimum amount (7.7 mg) among all fractions.

2.3. Quantitative Analysis of Bioactive Compounds from P. methysticum Root

Because the four compounds 5-hydroxy-4′,7-dimethoxyflavanone, matteucinol, 5,6-dehydrokavain and yangonin were purified, they were used as the standards to quantify their contents in P. methysticum root by GC-MS (Table 5). Of them, 5,6-dehydrokavain (DK) was the predominant component (2.75 mg/g DW), followed by matteucinol (2.50 mg/g DW) and yangonin (2.09 mg/g DW). The content of 5-hydroxy-4′,7-dimethoxyflavanone was minimum (0.76 mg/g DW).

2.4. Inhibitory Activity of the Isolated Compounds on the Growth of R. sativus

Table 6 showed that all isolated constituents from P. methysticum reduced elongation of R. sativus, although the levels of inhibition varied among compounds, their mixtures, shoot and root of radish. Among the four purified compounds, both of the two flavanones (C1, C2) (IC50 = 120.22, 248.03 µg/mL, respectively) exhibited much higher inhibitory activities on shoot elongation of R. sativus than the two lactones (C3, C5, IC50 = 265.88, 313.82 µg/mL, respectively). The mixtures C4 and C6 showed excellent suppression on root growth (IC50 = 7.70, 15.67 µg/mL, respectively), as compared to C3 and C5 (Table 6). The inhibitory magnitudes of C4 and C6 on root growth of R. sativus were much stronger than shoot elongation of other kavalactones as well as their mixtures and the two flavanones. The findings in Table 6 suggest that the mixtures of C4 and C6 may possess a novel mode of inhibitory action on plant root elongation. However, further trials on the effects of individual compounds in C4 and C6 on root growth of different indicator plants including weeds should be performed.

3. Discussion

In our previous research, eight phenolic compounds including gallic acid, protocatechuic acid, p-hydroxybenzoic acid, p-coumaric acid, ferulic acid, salicylic acid, trans-o-coumaric acid and trans-cinamic acid potentially involved in the weed suppressing ability of P. methysticum root were identified by high performance-liquid chromatography (HPLC) and thin layer chromatography (TLC) analyses [8]. The most phytotoxic spot visible from TLC reduced the shoot and root elongation of Echinochloa crus-galli (barnyard grass) by 80% and 95%, respectively. However, the isolation and purification of plant growth inhibitors other than phenolic acids were not achieved [8]. In another trial, six kavalactones, including methysticin, 7,8-dihydrokavain, 5,6-dehydrokavain, kavain, yangonin, dihydromethysticin were purchased and examined for their inhibitory activities against Lactuca sativa (lettuce), barnyard grass and some harmful fungi [9]. Dihydromethysticin was the most potential as it inhibited growth of lettuce by 80.4% by 10 µg/mL, whilst methysticin was the best at reducing barnyard grass emergence (by 66.6%) [9]. Although the efficacy of different extraction solvents on the chemical components in P. methysticum root was examined [11], the presence of the different constituents was analysed by only GC-MS [11]. Several attempts on isolation and purification of bioactive constituents have been carried out, but principally related to the medicinal and pharmaceutical properties of kavalactones, using HPLC, GC-MS and common analytical instruments [12,13,14,15,16,17]. Protocols for successfully isolating and purifying bioactive kavalactones as well as bioactive chemicals in P. methysticum root have not yet been reported.
The present study investigated the inhibitory effects of different solvent extracts of P. methysticum root on the growth of R. sativus. It was observed that levels of inhibition on root length were higher than on shoot elongation (Table 2). The phytotoxic effect on plant growth is dependent on the composition and concentration of growth inhibitors [18]. Secondary metabolites from plants including terpenoids, steroids, phenols, coumarins, alkaloids and flavonoids have been documented as allelochemicals [19]. Plant growth inhibitors or allelochemicals inhibit growth of neighboring plants by disturbing their physiological processes such as photosynthesis, respiration, water and hormonal balance [20]. The application of extraction solvents with different polarities is crucial to isolate and purify bioactive compounds in plants [21]. However, many natural products have complicated chemical structures, making their purification processes therefore sophisticated, laborious and time-consuming [22]. The pharmacological properties of P. methysticum beverages have attracted many researchers over the past 130 years in order to exploit the biologically active constituents [3,23]. To date, more than 40 compounds have been identified from P. methysticum root [24], predominantly belonging to kavalactones, chalcones and flavones and conjugated diene ketones [24], of which, kavalactones accounted for approximately 96% of the lipid extract and 3–20% by dry weight [24,25,26]. However, it was reported that chemotype and kavalactone contents in P. methysticum root were controlled by the plant organ, genetics and environmental factors [27].
This study found that among solvent extracts, the EtOAc one exhibited the maximal inhibitory effect on the growth of R. sativus, as compared to those of chloroform, acetone and hexane (Table 3). Li et al. [28] documented that suitable solvents achieved high yields of potential allelochemicals. Only seven kavalactones, including 5,6-dehydrokavain, kavain, yangonin, dihydro-5,6-dehydrokavain, 7,8-dihydrokavain, dihydromethysticin and methysticin were identified and quantified (Table 4 and Table 5), although a total of 18 kavalactones are known to be found in P. methysticum root [11]. The other known kavalactones were absent, thus suggested that they might correlate to much weaker inhibitory activity and be found in other extracts such as hexane, chloroform and water (Table 1 and Table 2). Among the identified constituents, though the flavanones C1 and C2 and the individual kavalactones C3 and C5 showed stronger inhibition, the mixtures of kavalactones in C4 and C6 were the most potent, as they inhibited root elongation of R. sativus by IC50 = 7.70 and 15.67 µg/mL, respectively (Table 6). The modes of action of the mixtures C4 and C6 on different indicator plants including weeds should be further investigated to examine whether they are actually potent enough for the development of novel herbicides.
In this research, the flavanone C1 was previously identified by GC-MS [9] and the flavanone C2 matteucinol was detected for the first time in P. methysticum root. This research successfully purified and quantified the two compounds and reported their stronger inhibitory activities than those of other kavalactones on growth of R. sativus (Table 6). Compound C1 (5-hydroxy-4′,7-dimethoxyflavanone) was reported as an antifungal and antioxidant substance in Argentinean propolis and some other herbal plants such as Piper caninum and Combretum zeyheri [29,30,31], while no information about biological activities of matteucinol was documented. To date, the mechanisms of flavanones other than allelopathy remain vague. It might be that their interference induces cell growth inhibition, ATP production disturbances and hinders the proper functioning of auxins [32].
The findings in Table 3 indicated that the combination of hexane-ethyl acetate at 9:1 and 8:2 ratios successfully yielded the pure flavanones C1 and C2 and kavalactones (C3, C5 and mixtures of C4 and C6). The mixture of kavain and yangonin in C4 and four kavalactones including dihydro-5,6-dehydrokavain, 7,8-dihydrokavain, dihydromethysticin and methysticin in C6 needed further purification by CC with a more effective combination of solvents. As P. methysticum is a Pacific herbal remedy which is highly recommended as a treatment for diseases related to nervous disorders such as anxiety, insomnia and stress [33], although the consumption of kava-containing products has been suspected of causing liver damage in a few cases [34,35,36,37]. In contrast, P. methysticum was also reported to be non-toxic to the liver, and it may even possess liver protective properties [38,39]. The protocols for purification of bioactive chemicals in P. methysticum root including flavanones and kavalactones developed by this study should prove useful to exploit more effectively the biological activities of this tropical herb. Alpinia zerumbet which also possesses kavalactones including DK and DDK [12,40,41,42,43] may be utilized these protocols to isolate potent flavanones and other kavalactones from this medicinal plant. The consumption of A. zerumbet as a dietary supplement which includes the bioactive constituents DK and DDK by Okinawans was recorded in a study of the longevity of Japanese people living in islands of the Ryukyus [44]. As DK and DDK are the two kavalactones [9,11,40,41,42,43,44], whether the use of P. methysticum root as a traditional beverage contributes to the health and longevity of Polynesian and Pacific islanders needs further investigation.

4. Materials and Methods

4.1. Plant Materials

4.1.1. Piper methysticum Root

Commercial dried P. methysticum root was purchased from Kava King Products, Inc. (Ormond Beach, FL, USA) on 2 May 2017. The root powder was stored in the freezer at the temperature of −20 °C prior to extraction.

4.1.2. Tested Plants

Seeds of R. sativus were purchased from Taki Co. Ltd. (Kyoto, Japan). Empty and unhealthy seeds were removed by floating in tap water. After air-drying, the selected seeds were treated with 0.1% sodium hypochlorite for 30 min and then washed by sterile water in triplicate.

4.2. Preparation of Plant Extract

Dried Piper methysticum root powder (907.2 g) was extracted with 3 L of acetone solvent for 2 week at room temperature. After filtration using filter paper (Whatman No.5C, 110 mm), the residue was evaporated to dryness by a rotary evaporator (SB-350, EYELA, Tokyo, Japan) at 45 °C and yielded 49.39 g of crude acetone extract. An amount of 1.5 g the acetone crude extract was dissolved with methanol (MeOH) to enhance the solubility in bioassays and different dilutions (50, 250 and 500 µg/mL) were thus obtained. The remaining acetone crude extract (47.89 g) was dissolved in 100 mL distilled water and fractionated subsequently with hexane, chloroform and ethyl acetate. This resulted in 0.42 g of hexane (0.9%), 46.86 g of chloroform (99.94%), 2.6 g of EtOAc (5.54%) and 0.34 g of water (0.73%) extracts. All extracts were temporarily stored at −5 °C in the dark before the bioassays.

4.3. Inhibitory Activity of P. methysticum Root Crude Extracts

Inhibitory assays were performed to measure the effects of various concentrations of P. methysticum root extract on R. sativus growth inhibition. Three dilutions (50, 250 and 500 µg/mL) of each crude extract were prepared for this study. After that, each ten surface-sterilized seeds were placed in a Petri dish lined with a filter paper moistened with 200 mL of each tested solution. Water was used as a control. Treatments were designed randomly with three replicates. The R. sativus seed growth was observed under a condition of 25/23 °C temperature over photoperiod 12/12 h day/night inside a growth chamber (Biotron NC system, Nippon Medical & Chemical Instrument, Co. Ltd., Osaka, Japan). After 5 days, root length and shoot height were recorded to determine the inhibitory levels on of seedling growth and expressed by IC50 values. The extract showed the strongest inhibition on the germination and growth of R. sativus was further fractionated.

4.4. Isolation and Purification of Bioactive Compounds

4.4.1. General Experimental Procedures

Column chromatography (20 mm diameter × 500 mm height, Climbing G2, Tokyo, Japan) was performed using silica gel (size Ǻ 60, 200–400 mesh particle size, Sigma-Aldrich, Tokyo, Japan). Thin layer chromatography (TLC) was conducted by TLC plates with layer thickness was 0.25 mm. The TLC spots were observed by spraying with EtOAc:H2SO4 (95:5) followed by heating at 100 °C in an oven (Laboratory Convection Oven MOV-212F D, SANYO, Gunma, Japan) for 3 min. GC-MS analysis was run on a JMS-T100 GCV system (JEOL Ltd., Tokyo, Japan). The compound identification was carried out by comparing the mass spectral fragmentation patterns of the samples with the mass spectral libraries of JEOL’s GC-MS Mass Center System Version 2.65a software. The electrospray ionization-mass spectrometry (ESI-MS) experiments were performed in a LTQ Orbitrap XL mass spectrometer (Thermo Scientific, Bremen, Germany). The nuclear magnetic resonance spectra (1H-NMR at 400.13 Hz and 13C-NMR at 100.612 Hz) were recorded with a model 500 spectrometer (Bruker Yokohama, Japan) with samples dissolved in CDCl3.

4.4.2. Isolation, Purification and Identification by CC, GC-MS, EIS-MS, 1H- and 13C-NMR

Dried powder of Piper methysticum root (165.9 g) was extracted with a solvent system of acetone-acetonitrile (4:1) for one week at room temperature. The extract was then filtered and dried under reduced pressure using a rotary evaporator at 45 °C. The obtained crude extract (9.4 g) was suspended in distilled water and partitioned in a separatory funnel with hexane (H) and EtOAc (E). The most active EtOAc extract was evaporated to yield 6.5 g of crude extract. After thin layer chromatography (TLC) analysis, the EtOAc extract was chromatographed on a column (20 mm diameter × 500 mm height, Climbing G2, Tokyo, Japan) over silica gel (size Ǻ 60, 200–400 mesh particle size, Sigma-Aldrich, Tokyo, Japan). The elution was conducted using sequential solvent systems of increasing polarity (n-hexane-EtOAc 10:0–0:10 v/v), followed by MeOH 100%. Similar fractions (frs.; each of 100 mL) as observed by TLC were pooled together and concentrated to dryness using a rotary evaporator. Six fractions crystallized at room temperature, of which, four were pure compounds and other were mixtures. All isolated compounds and the mixtures were analysed and confirmed by GC-MS and ESI-MS, 1H-NMR and 13C-NMR to determine their chemical structures.
5-Hydroxy-4′,7-dimethoxyflavanone (C1). Compound C1 was isolated as a white powder from the combined fractions 14–17, which were eluted with 9:1 H-E. This compound was purified after eluting by hexane and filtering through a filter paper to remove contaminants. The purity of the substance was determined to be 93.28% by GC-MS analysis (Supplementary Material, Figure S1). Its molecular formula was identified to be C17H16O5 based on ESI-MS: m/z 301.1 [M − H]+ (Supplementary Material, Figure S2). The identification as 5-hydroxy-4′,7-dimethoxyflavanone (Figure 1) was obtained by analysis of its 1H- and 13C-NMR spectra and literature data [34]. 1H-NMR δ (ppm): 12.8 (1H, s); 7.78 (2H, dd, 8 Hz, 4 Hz, H2′ and H6′); 6.97 (2H, dd, 8 Hz, 4 Hz, H3′and H5′); 6.52 (1H, s, H3); 6.43 (1H, d, 4 Hz, H8); 6.32 (1H, d, 4 Hz, H6); 3.86(3H, s); 3.85 (3H, s).13C-NMR δ (ppm): 163.9 (C2), 104.2 (C3), 182.4 (C4), 162.0 (C5), 98.0 (C6), 165.3 (C7), 92.5 (C8), 157.6 (C9), 105.4 (C10), 123.4 (C1′), 127.9 (C2′), 114.4 (C3′), 162.5 (C4′), 114.4(C5′), 127.9 (C6′), 55.8 (C6′–OCH3), 55.5(C7–OCH3). (Supplementary Material, Figures S3 and S4).
5,7-Dihydroxy-4′-methoxy-6,8-dimethylflavanone (C2). Compound C2 was precipitated as a yellow powder from fractions 20–26 which were eluted with 9:1 H-E. Hexane was used to purify this compound. The molecular formula of compound C2 was identified as C18H18O5 based on ESI-MS: m/z 314.12 [M − H]+ while the purity was 90% using GC-MS analysis (Supplementary Material, Figure S6). The identification as 5,7-dihydroxy-4′-methoxy-6,8-dimethylflavanone or matteucinol (Figure 1) was obtained by analysis of its 1H- and 13C-NMR spectra and literature data [45]. 1H-NMR δ (ppm): 2.03(3H, s, 6-CH3), 2.05 (3H, s, 8-CH3), 2.78 (1H, dd, J = 17 Hz, 3 Hz, H-3β), 3.03 (1H, dd, J = 17 Hz, 13 Hz, H-3α), 3.83 (3H, s, OCH3), 5.32 (1H, dd, J = 13 Hz, 3 Hz, H-2), 6.95 (2H, d, J = 9 Hz, H-3′,5′), 7.39 (2H, d, J = 9 Hz, H-2′,6′), 12.29 (1H, s, chelated 5-OH). 13C-NMR δ (ppm): 6.9 (6-CH3), 7.6 (8-CH3), 43.1 (3α, 3β), 55.2 (OCH3), 78.2 (C-1), 102.3 (C-8), 102.7 (C-10), 103.5 (C-6), 114.0 (C-3′,5′), 127.4 (C-2′,6′), 131.0 (C-1′), 157.7 (C-9), 158.8 (C-5), 159.6 (C-4′), 162.1 (C-7), 196.5 (C-4) (Supplementary Material, Figures S6–S12).
5,6-Dehydrokavain (C3). Compound C3 was isolated as pale-yellow needles from fractions 11–15 which were eluted with 8:2 H-E. Hexane was also used to purify this compound with the purity being evaluated as 94.66% by GC-MS (Supplementary Material, Figure S13). According to ESI-MS data (m/z: 229.1 [M − H]+, Supplementary Material, Figure S14), the molecular formula of compound C3 was determined as C14H14O3. The 1H- and 13C-NMR results were interpreted to match 5,6-dehydrokavain (Figure 1) by compared with spectroscopic data in the literature [12]. ESI-MS: 229.1 [M + H]+; 1H-NMR δ (ppm): 3.87 (3H, s, MeO-), 5.62 (1H, d; J = 2.2 Hz, 3-H), 6.24 (1H, d; J = 2.2 Hz, 5-H), 6.86 (1H, d; J = 16 Hz, 7-H), 7.43 (1H, d; J = 16 Hz, 8-H), 7.36–7.59(5H, m, aromatic); 13C-NMR (δ (ppm): 56.61 (MeO-), 89.50 (C-3), 102.73 (C-5), 120,12 (C-7), 128.10 (C-14), 128,44 (C-10), 129,41 (C-13), 129.52 (C-11), 130.23 (C-12), 136.31 (C-9), 136.74 (C-8), 160.55 (C-2), 166.63 (C-6), 173.34 (C-4) (Supplementary Material, Figures S15 and S16).
Yangonin (C5). Fractions 48–55 were eluted with a solvent system of 8:2 H-E to yield 70.3 mg of yangonin (as light yellow needles). Its molecular formula was established to be C15H14O4 on the basis of ESI-MS: m/z 259.1 [M − H]+ (Supplementary Material, Figure S20). The combined fractions were eluted with a 6:4 H-E solvent mixture to obtain the pure compound. The purity of yangonin reached 93.64% according to GC-MS result (Supplementary Material, Figure S19). The compound was identified as yangonin (Figure 1) by comparison between its 1H- and 13C-NMR spectra with the spectroscopic data reported in the literature [46]. 1H-NMR δ (ppm): 5.45 (d, J = 2.1 Hz, H-3); 5.87 (d, J = 2.1 Hz, H-5); 6.43 (d, J = 16.0 Hz, H-7); 7.43 (d, J = 16.0 Hz, H-8); 7.42 (d, J = 8.8 Hz, H-10 and H-14); 6.88 (d, J = 8.8 Hz, H-11 and H-13); 3.82 (s, 4-OMe); 3.79 (s, 12-OMe). 13C-NMR δ (ppm): 164.1 (C-2), 88.3 (C-3), 171.2 (C-4), 100.4 (C-5), 159.0 (C-6), 116.3 (C-7), 135.4 (C-8), 127.9 (C-9), 1289 (C-10), 114.3 (C-11), 160.7 (C-12), 114.3 (C-13), 128.9 (C-14), 55.8 (4-OMe), 55.3 (12-OMe) (Supplementary Material, Figures S21 and S22).

4.4.3. Chemical Identification and Quantification

GC-MS Analysis

To elucidate the name, structure and chemical properties of the identified constituents, GC-MS analysis was performed. One µL aliquot of each compound was diluted in chloroform to obtain 1000 µg/mL concentration. After that, the solvents were injected into the GC-MS system equipped with a DB-5MS capillary column, 30 m in length, 0.25 mm internal diameter and 0.25 µm in thickness (Agilent Technologies, J & W Scientific Products, Folsom, CA, USA). The data were recorded using helium as carrier gas. At the beginning of the program, the GC oven temperature program was set up at 50 °C without any hold time, then increased to 300 °C at a rate of 10 °C/min and finally held for 30 min at 300 °C. The injector and detector temperature were set at 300 °C and 320 °C, respectively, with a mass scan range from 29 to 800 amu. The compound identification was carried out by comparing the mass spectral fragmentation patterns of the samples with the mass spectral libraries of JEOL’s GC-MS Mass Center System Version 2.65a and standards.

Quantification of Growth Inhibitors of P. methysticum Root

Four pure compounds C1, C2, C3, and C5 were used as standards for the quantitative analysis. Those compounds were dissolved in chloroform to obtain different concentrations (10, 25, 50 ppm). The quantification was performed using similar GC conditions between the standards and samples. The retention time and areas of the standards and samples were compared to obtain standard curves (r2 > 0.9). The content value of quantified compounds was expressed in milligrams per gram of dry weight (mg/g DW).

ESI/MS Analysis

In ESI/MS analysis, the chemicals were solubilized in chloroform-d (CDCl3) to obtain a concentration of 50 µg/mL. All measurements were conducted on mass spectrometer with electrospray ion source. Negative/positive ion mode was used with a capillary temperature of 140 °C (120 °C for S2) and a spray voltage of 3.0 kV (2.7 kV for S2). The measurements were performed in the positive mode with an ion spray voltage of 3000 V and a capillary temperature of 350 °C. Data were collected in full scan mode within the range 280 to 1000 m/z.

NMR Analysis

The samples were dissolved in chloroform-d (CDCl3). The spectroscopic data were compared with those of literature to identify the structure of isolated organic compounds.

4.5. Inhibitory Activity of Isolated Compounds in Bioassays

Different dilutions (5, 10, 50, 100, 250 and 500 µg/mL) of isolated compounds and their mixture distilled in MeOH were prepared to check the germination rate of R. sativus seeds. All test plant seeds were soaked in distilled water to remove the empty and undeveloped seeds. Each five remaining seeds were sown in each 12 well-plate (22.1 mm diameter × 35 mm height) with filter paper moistened by 100 mL test compound solvent in triplicate. Methanol was used as the controls. After that, all test plates were kept for 5 days in a growth chamber set at 25 °C ± 2 °C with 8/16 h day/night cycle. The root lengths and shoot heights were measured and the concentration reducing 50% of seedling growth was calculated (IC50).

4.6. Statistical Analysis

The statistical analyses were implemented by Minitab® 16.2.3 (copyright © 2012 Minitab Inc., Philadelphia, PA, USA). Mean and standard deviation values were evaluated using one-way ANOVA. Turkey’s test was applied to compare significant differences between treatment, control and standard data various results at p < 0.05.

5. Conclusions

The findings of this study revealed that P. methysticum roots contain a number of potent plant growth inhibitors. The use of combinations of hexane-ethyl acetate at 9:1 and 8:2 ratios in column chromatography resulted in the successful isolation and purification of two flavanones C1 and C2, of which the C2 (matteucinol) was detected for the first time in P. methysticum root and kavalactones C3C6, of which the C2 (matteucinol) was the first time detected in P. methysticum root. The ethyl acetate extract showed the strongest inhibitory level as compared with hexane, chloroform, acetone and water ones. The isolated flavanones C1 and C2 and kavalactones (C3C6) showed reversed different levels of activity on elongation of shoot and root of S. sativus, suggesting that they may possess distinct modes of action. This study established an efficacious extraction and purification protocol for the bioactive constituents, principally kavalactones and flavanones in P. methysticum roots, to aid effective exploitation of the potential use of this herbal plant for the development of natural herbicides as well as medicines and pharmaceutics.

Supplementary Materials

The following are available online, Figures S1–S24 are provided.

Author Contributions

T.M.V. and T.D.X. conceived and designed the experiments. T.M.V. and T.N.M. conducted the experiments, analysed the data and wrote the manuscripts. T.D.X. and N.V.Q. gave advice and revised the manuscript. All authors approved the final version of the manuscript.

Funding

This research received no external funding.

Acknowledgments

We thank Phung Thi Tuyen for helpful advice to this research.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Rice, E.L. Allelopathy, 2nd ed.; Academic Press Inc.: Orlando, FL, USA, 1984; p. 422. ISBN 0125870558. [Google Scholar]
  2. Khanh, T.D.; Chung, I.M.; Xuan, T.D.; Tawata, S. The exploitation of crop allelopathy in sustainable agricultural production. J. Agron. Crop Sci. 2005, 191, 172–184. [Google Scholar] [CrossRef]
  3. Singh, Y.N. Kava: An overview. J. Ethnopharmacol. 1992, 37, 13–45. [Google Scholar] [CrossRef]
  4. Blumenthal, M. Kava safety questioned due to case reports of liver toxicity. Herbal Gram 2002, 55, 26–32. [Google Scholar]
  5. Meyer, H.J. Pharmacology of kava. In Ethnopharmacologic Search for Psychoactive Drugs, 2nd ed.; Efron, D.H., Holmstedt, B., Kline, N.S., Eds.; Raven Press: New York, NY, USA, 1979; ISBN 9780300052138. [Google Scholar]
  6. Lebot, V.; Merlin, M.; Lindstrom, L. Kava: The Pacific Drug; Yale University Press: New Haven, CT, USA, 1992; ISBN-10 0300052138, ISBN-13 978-0300052138. [Google Scholar]
  7. Hong, N.H.; Xuan, T.D.; Tsuzuki, E.; Matsuo, M.; Ogushi, Y. Evaluation of the allelopathic potential of kava (Piper methysticum L.) for weed control in rice (Oryza sativa). Weed Biol. Manag. 2002, 2, 143–147. [Google Scholar] [CrossRef]
  8. Xuan, T.D.; Eiji, T.; Hiroyuki, T.; Mitsuhiro, M.; Khanh, T.D. Identification of potential allelochemicals from kava (Piper methysticum L.) root. Allelopath. J. 2003, 12, 197–203. [Google Scholar]
  9. Xuan, T.D.; Elzaawely, A.A.; Fukuta, M.; Tawata, S. Herbicidal and fungicidal activities of lactones in Kava (Piper methysticum). J. Agric. Food Chem. 2006, 54, 720–725. [Google Scholar] [CrossRef] [PubMed]
  10. Xuan, T.D.; Tawata, S.; Khanh, T.D.; Chung, I.M. Decomposition of allelopathic plants in soil. J. Agron. Crop Sci. 2005, 191, 162–171. [Google Scholar] [CrossRef]
  11. Xuan, T.D.; Fukuta, M.; Wei, A.C.; Elzaawely, A.A.; Khanh, T.D.; Tawata, S. Efficacy of extracting solvents to chemical components of kava (Piper methysticum) roots. J. Nat. Med. 2008, 62, 188–194. [Google Scholar] [CrossRef] [PubMed]
  12. Junior, R.W.A.; Gomes, D.B.; Zanchet, B.; Schönell, A.P.; Diel, K.A.; Banzato, T.P.; Ruizc, A.L.T.G.; Carvalhoc, J.E.; Neppel, A. Antiproliferative effects of pinostrobin and 5,6-dehydrokavain isolated from leaves of Alpinia zerumbet. Rev. Bras. Farmacogn. 2017, 27, 592–598. [Google Scholar] [CrossRef]
  13. Whitton, P.A.; Lau, A.; Salisbury, A.; Whitehouse, J.; Evans, C.S. Kava lactones and the kava-kava controversy. Phytochemistry 2003, 64, 673–679. [Google Scholar] [CrossRef]
  14. Dragul, K.; Yoshida, W.Y.; Tang, C. Piperidine alkaloids from Piper methysticum. Phytochemistry 2003, 63, 193–198. [Google Scholar] [CrossRef]
  15. Wu, D.; Yu, L.; Nair, M.G.; DeWitt, D.L.; Ramsewak, R.S. Cyclooxygenase enzyme inhibitory compounds with antioxidant activities from Piper methysticum (kava kava) roots. Phytomedicine 2002, 9, 41–47. [Google Scholar] [CrossRef] [PubMed]
  16. Bilia, A.R.; Bergonzi, M.C.; Lazari, D.; Vinceiri, F.F. Characterization of commercial kava-kava herbal drug and herbal drug preparations by means of nuclear magnetic resonance spectroscopy. J. Agric. Food Chem. 2002, 50, 5016–5025. [Google Scholar] [CrossRef] [PubMed]
  17. Meissner, O.; Haberlein, H. HPLC analysis of flavokavins and kavapyrones from Piper methysticum Forst. J. Chromatogr. B 2005, 826, 46–49. [Google Scholar] [CrossRef] [PubMed]
  18. Asaduzzaman, M.D.; Islam, M.M.; Sultana, S. Allelopathy and allelochemicals in rice weed management. Bangladesh Res. Publ. J. 2010, 4, 1–14. [Google Scholar]
  19. Seigler, D.S. Chemistry and mechanisms of allelopathic interactions. Agron. J. 1996, 88, 876–885. [Google Scholar] [CrossRef]
  20. Soltys, D.; Krasuska, U.; Bogatek, R.; Gniazdowska, A. Allelochemicals as bioherbicides—Present and perspectives. In Herbicides—Current Research and Case Studies in Use; Price, A.J., Kelton, J.A., Eds.; Intech: Rijeka, Croatia, 2013; ISBN 978-953-51-1112-2. [Google Scholar]
  21. Andriana, Y.; Xuan, T.D.; Quan, N.V.; Quy, T.N. Allelopathic potential of Tridax procumbens L. on radish and identification of allelochemicals. Allelopathy J. 2018, 43, 223–237. [Google Scholar] [CrossRef]
  22. Altemimi, A.; Lakhssassi, N.; Baharlouei, A.; Watson, D.G.; Lightfoot, D.A. Phytochemicals: Extraction, Isolation, and Identification of Bioactive Compounds from Plant Extracts. Plants 2017, 6, 42. [Google Scholar] [CrossRef] [PubMed]
  23. Singh, Y.N.; Blumenthal, M. Kava: An overview. Herbal Gram 1997, 39, 34–55. [Google Scholar] [CrossRef]
  24. Rowe, A.; Zhang, L.Y.; Ramzan, I. Toxicokinetics of kava. Adv. Pharmacol. Sci. 2010, 2011, 1–6. [Google Scholar] [CrossRef] [PubMed]
  25. Teschke, R.; Lebot, V. Proposal for a kava quality standardization code. Food Chem. Toxicol. 2011, 49, 2503–2516. [Google Scholar] [CrossRef] [PubMed]
  26. Bhat, Z.S.; Rather, M.A.; Maqbool, M.; Lah, H.U.; Yousuf, S.K.; Ahmad, Z. α-pyrones: Small molecules with versatile structural diversity reflected in multiple pharmacological activities-an update. Biomed. Pharmacother. 2017, 91, 265–277. [Google Scholar] [CrossRef] [PubMed]
  27. Siméoni, P.; Lebot, V. Identification of factors determining kavalactone content and chemotype in kava (Piper methysticum Forst. f.). Biochem. Syst. Ecol. 2002, 30, 413–424. [Google Scholar] [CrossRef]
  28. Li, B.B.; Smith, B.; Hossain, M.d.M. Extraction of phenoloics from citrus peels I. Solvent extraction method. Sep. Purif. Technol. 2006, 48, 182–188. [Google Scholar] [CrossRef]
  29. Vera, N.; Solorzano, E.; Ordoñez, R.; Maldonado, L.; Bedascarrasbure, E.; Isla, M.I. Chemical composition of Argentinean propolis collected in extreme regions and its relation with antimicrobial and antioxidant activities. Nat. Prod. Commun. 2011, 6, 823–827. [Google Scholar] [PubMed]
  30. Wan, W.M.N.H.S.; Ahmad, F.; Yen, K.H. Essential oils, phytochemicals and bioactivities of Piper caninum Blume. In Natural Heterocycles: Extraction and Biological Activity; Ameta, K.L., Ed.; Nova Science Publishers Inc.: London, UK, 2015; ISBN 978-163-463-462-5. [Google Scholar]
  31. Mangoyi, R.; Midiwo, J.; Mukanganyama, S. Isolation and characterization of an antifungal compound 5-hydroxy-7,4’-dimethoxyflavone from Combretum zeyheri. BMC Complement. Altern. Med. 2015, 15. [Google Scholar] [CrossRef] [PubMed]
  32. Mierziak, J.; Kostyn, K.; Kulma, A. Flavonoids as important molecules of plant interactions with the environment. Molecules 2014, 19, 16240–16265. [Google Scholar] [CrossRef] [PubMed]
  33. Rouse, J. Kava: A South Pacific herb for anxiety, tension and insomnia. Clin. Nutr. Insights 1998, 96, 3900–3905. [Google Scholar]
  34. Teschke, R.; Sarris, J.; Schweitzer, I. Kava hepatotoxicity in traditional and modern use: The presumed Pacific kava paradox hypothesis revisited. Br. J. Clin. Pharmacol. 2012, 73, 170–174. [Google Scholar] [CrossRef] [PubMed]
  35. Rowe, A.; Ramzan, I. Are mould hepatotoxins responsible for kavahepatotoxicity? Phytother. Res. 2012, 26, 1768–1770. [Google Scholar] [CrossRef] [PubMed]
  36. Grace, R.F. Kava drinking in Vanuatu—A hospital based survey. Pac. Health Dialog. 2003, 10, 41–44. [Google Scholar] [PubMed]
  37. Zhou, P.; Gross, S.; Liu, J.H.; Yu, B.Y.; Feng, L.L.; Nolta, J.; Piwnica-Worms, D.; Qiu, S.X. Flavokawain B, the hepatotoxic constituent from kava root, induces GSH-sensitive oxidative stress through modulation of IKK/NF-κB and MAPK signaling pathways. FASEB J. 2010, 24, 4722–4732. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Singh, Y.N.; Devkota, A.K. Aqueous kava extracts do not affect liver function tests in rats. Planta Med. 2003, 69, 496–499. [Google Scholar] [PubMed]
  39. DiSilvestro, R.A.; Zhang, W.; DiSilvestro, D.J. Kava feeding in rats does not cause liver injury nor enhance galactosamine-induced hepatitis. Food Chem. Toxicol. 2007, 45, 1293–1300. [Google Scholar] [CrossRef] [PubMed]
  40. Xuan, T.D.; Teschke, R. Dihydro-5,6-dehydrokavain (DDK) from Alpinia zerumbet: Its isolation, synthesis, and characterization. Molecules 2015, 20, 16306–16319. [Google Scholar] [CrossRef] [PubMed]
  41. Elzaawely, A.A.; Xuan, T.D.; Tawata, S. Changes in essential oils, kava pyrones and total phenolics of Alpinia zerumbet (Pers.) B.L. Burtt. & R.M. Sm. leaves exposed to copper sulphate. Environ. Exp. Bot. 2007, 59, 347–353. [Google Scholar]
  42. Elzaawely, A.A.; Xuan, T.D.; Tawata, S. Essential oils, kava pyrones and phenolic compounds from leaves and rhizomes of Alpinia zerumbet (Pers.) B.L. Burtt. & R.M. Sm. and their antioxidant activity. Food Chem. 2007, 103, 486–494. [Google Scholar]
  43. Tawata, S.; Fukuta, M.; Xuan, T.D.; Deba, F. Total utilization of tropical plants Leucaena leucocephala and Alpinia zerumbet. J. Pest. Sci. 2008, 33, 40–43. [Google Scholar] [CrossRef]
  44. Teschke, R.; Xuan, T.D. Viewpoint: A contributory role of shell ginger (Alpinia zerumbet) for human longevity in Okinawa, Japan? Nutrients 2018, 10, 166. [Google Scholar] [CrossRef] [PubMed]
  45. Suyatno, S.; Syarief, S.H.; Hidajati, N.; Rinningsih, R.; Tori, M.; Shimizu, K. Phenolic compounds isolated from the fern Chingia sakayensis (Zeiller). J. ILMU DASAR 2009, 10, 22–29. [Google Scholar]
  46. Wongsa, N.; Kanokmedhakul, K.; Boonmak, J.; Youngme, S.; Kanokmedhakul, S. Bicyclic lactones and racemic mixtures of dimeric styrylpyrones from the leaves of Miliusa velutina. RSC Adv. 2017, 7, 25285–25297. [Google Scholar] [CrossRef]
Sample Availability: Samples of the compounds are available from the authors.
Figure 1. Chemical structures of bioactive constituents from P. methysticum root.
Figure 1. Chemical structures of bioactive constituents from P. methysticum root.
Molecules 23 01907 g001aMolecules 23 01907 g001b
Table 1. Effect of different extracts of Piper methysticum root on growth of R. sativus.
Table 1. Effect of different extracts of Piper methysticum root on growth of R. sativus.
ExtractConcentration (µg/mL)Shoot Inhibition (%)Root Inhibition (%)
Hexane5022.62 ± 3.15 d28.00 ± 3.73 i
25055.33 ± 3.06 c70.54 ± 3.82 d
50068.67 ± 3.06 b89.52 ± 3.36 bc
Chloroform5025.40 ± 2.75 d36.67 ± 3.51 g
25074.00 ± 2.61 ab88.48 ± 3.94 bc
50081.00 ± 3.61 a98.57 ± 3.43 a
EtOAc5024.79 ± 3.39 d39.33 ± 3.76 fg
25078.33 ± 2.08 ab94.87 ± 3.75 ab
50083.67 ± 4.51 a99.05 ± 3.83 a
Acetone5024.13 ± 4.29 d36.11 ± 3.47 gh
25068.67 ± 3.12 b85.62 ± 2.72 c
50078.00 ± 2.00 ab95.86 ± 3.21 ab
Water5023.29 ± 4.02 d29.00 ± 3.00 hi
25030.67 ± 2.31 d44.83 ± 3.16 ef
50051.33 ± 7.02 c50.48 ± 3.18 e
Values represent means ± SD (standard deviation). Values in a column with different letters are significantly different (p < 0.05).
Table 2. Effect of P. methysticum root extracts on growth of R. sativus (IC50 values).
Table 2. Effect of P. methysticum root extracts on growth of R. sativus (IC50 values).
ExtractsInhibitory Levels, IC50 (µg/mL)
ShootRoot
Hexane278.60 ± 19.30 b173.70 ± 15.44 b
Chloroform181.09 ± 8.64 c81.40 ± 26.80 c
Ethyl acetate172.00 ± 25.20 c51.31 ± 0.23 c
Acetone206.36 ± 1.88 bc90.50 ± 21.00 c
Water483.80 ± 71.70 a420.30 ± 53.20 a
Values represent means ± SD (standard deviation); Values in a column with different letters are significantly different (p < 0.05).
Table 3. Fractions isolated from Piper methysticum root by column chromatography.
Table 3. Fractions isolated from Piper methysticum root by column chromatography.
FractionSolvent Combination and FractionWeight (mg)
C1Crystal in H-E 9:1 (fractions 14–17)7.7
C2Crystal in H-E 9:1 (fractions 20–26)54.7
C3Crystal in H-E 8:2 (fractions 11–15)174.4
C4Crystal in H-E 8:2 (fractions 32–47)518.0
C5Crystal in H-E 8:2 (fractions 48–55)70.3
C6Crystal in H-E 8:2 (fractions 69–74)49.0
H: hexane; E: ethyl acetate.
Table 4. Identification of bioactive compounds from EtOAc extract of P. methysticum root by GC-MS, ESI-MS and 1H- and 13C-NMR.
Table 4. Identification of bioactive compounds from EtOAc extract of P. methysticum root by GC-MS, ESI-MS and 1H- and 13C-NMR.
FractionRetention TimePeak Area (%)CompoundsChemical FormulaMolecular WeightChemical Class
C123.4093.285-Hydroxy-4′,7-dimethoxyflavanoneC17H16O5300Flavanone
C225.3790.00MatteucinolC18H18O5314Flavanone
C320.8094.665,6-Dehydrokavain (DK)C14H12O3228Kavalactone
C420.0759.42KavainC14H14O3230Kavalactone
23.3740.58YangoninC15H14O4258Kavalactone
C523.3493.64YangoninC15H14O4258Kavalactone
C616.2512.78Dihydro-5,6-dehydrokavain (DDK)C14H14O3230Kavalactone
18.3520.447,8-DihydrokavainC14H16O3232Kavalactone
22.4554.77DihydromethysticinC15H16O5276Kavalactone
23.408.90MethysticinC15H14O5274Kavalactone
Table 5. Quantity of purified compounds from P. methysticum root.
Table 5. Quantity of purified compounds from P. methysticum root.
FractionsRetention TimeCompoundsmg/g DW
C123.38 ± 0.015-Hydroxy-4′,7-dimethoxyflavanone0.76
C225.36 ± 0.02Matteucinol2.50
C320.65 ± 0.015,6-Dehydrokavain2.75
C523.34 ± 0.01Yangonin2.09
DW: dry weight.
Table 6. Inhibitory activity of isolated compounds from P. methysticum root on growth of R. sativus (IC50 values).
Table 6. Inhibitory activity of isolated compounds from P. methysticum root on growth of R. sativus (IC50 values).
FractionsCompoundsIC50 (µg/mL)
ShootRoot
C15-Hydroxy-4′,7-dimethoxyflavanone120.22 ± 14.64 e-
C2Matteucinol248.03 ± 5.43 d-
C35,6-Dehydrokavain (DK)265.88 ± 19.78 c,d375.33 ± 11.93 a
C4Kavain; yangonin457.18 ± 28.64 a7.70 ± 1.57 b
C5Yangonin313.82 ± 0.68 b,c365.00 ± 44.00 a
C6Dihydro-5,6-dehydrokavain (DDK); 7,8-dihydrokavain; dihydromethysticin; methysticin360.19 ± 20.37 b15.67 ± 5.13 b
Values represent means ± SD (standard deviation). -: measurements were not conducted. Values in a column with different letters are significantly different (p < 0.05).

Share and Cite

MDPI and ACS Style

Van, T.M.; Xuan, T.D.; Minh, T.N.; Quan, N.V. Isolation and Purification of Potent Growth Inhibitors from Piper methysticum Root. Molecules 2018, 23, 1907. https://doi.org/10.3390/molecules23081907

AMA Style

Van TM, Xuan TD, Minh TN, Quan NV. Isolation and Purification of Potent Growth Inhibitors from Piper methysticum Root. Molecules. 2018; 23(8):1907. https://doi.org/10.3390/molecules23081907

Chicago/Turabian Style

Van, Truong Mai, Tran Dang Xuan, Truong Ngoc Minh, and Nguyen Van Quan. 2018. "Isolation and Purification of Potent Growth Inhibitors from Piper methysticum Root" Molecules 23, no. 8: 1907. https://doi.org/10.3390/molecules23081907

APA Style

Van, T. M., Xuan, T. D., Minh, T. N., & Quan, N. V. (2018). Isolation and Purification of Potent Growth Inhibitors from Piper methysticum Root. Molecules, 23(8), 1907. https://doi.org/10.3390/molecules23081907

Article Metrics

Back to TopTop